close Call Us (401) 453-7900
  • Surgical Weight Loss

    Free informational seminars are offered monthly at Kent and Memorial Hospital by our surgical weight loss team.

    Sign up & learn more!
  • Your Heart Health

    Protecting your heart is one of the most important things you can do. Learn how Care New England can help.

    Learn More
  • Young Adult Mental Health

    The Young Adult Partial Hospital Program at Butler is designed to meet the specific needs of 18 to 26 year olds.

    Learn More
Find a Physician

Featured Physician

Jeannine Giovanni, MD

Jeannine Giovanni, MD

Jeannine Giovanni, MD

Jeannine Giovanni, MD

Jeannine Giovanni, MD, is director of bariatric surgery at Care New England. She has performed more than 2,000 laparoscopic bariatric procedures and hosts surgical weight loss information sessions monthly at Kent and Memorial hospitals.

Phone: 401-736-3731

Announcements

The Providence Center Introduces New Nursing Advancement Initiative

The Providence Center (TPC) recently rolled out the Nursing Clinical Advancement Program, a four-stage scaled curriculum that recognizes and rewards nurses for professional growth. The program is designed to help nurses advance their practice through leadership incentives and skill development while remaining at TPC. Details

Man Travels from Thailand to Memorial for Sleep Expert

Eden Weinmann hadn’t had a good night’s sleep in 30 years. Scoliosis arcs his spine into a dramatic 103-degree curve, making it difficult to breathe when he would lie down to sleep. When he did drift off, the curvature triggered gastroesophageal reflux disorder (GERD), high blood pressure and a pressing need to urinate several times a night, all of which would disrupt his rest. Details

Preliminary Research Results Show Promise for Alzheimer’s Treatment

Researchers at Butler Hospital publish breakthrough results from a study of a new drug for Alzheimer’s disease. The clinical trial covered a novel antibody therapy for Alzheimer’s disease, called aducanumab. In the study, researchers demonstrate the antibody’s ability to reduce amyloid plaque in the brain and slow cognitive decline, two major markers of Alzheimer’s disease. Details

E-Newsletter Sign UP